Adult Atopic Dermatitis Research Trial (30 Weeks)

Adults aged 18 to 55 years old with chronic atopic dermatitis (AD) present for 1 year or more, may qualify to participate. Individuals must have moderate to severe AD with involvement of 10% or more body surface area (BSA). A history of inadequate response to treatment with topical medications; or determination that topical treatments are otherwise medically inadvisable, is also required.

Participants will receive investigational medication (active study drug) or placebo, via subcutaneous injection. At Week 12, participants will receive one dose each of 2 commercially available vaccines. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 30 weeks and involve about 11 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more